Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.38%. A quarter ago, it was expected that this infectious disease drug developer would post earnings of $0.08 per share when it actually produced earnings of $0.13, delivering a surprise of 62.50%.Over the last fo ...